← Leaderboards
Qin Liu
Wistar Institute
$2,476,314
Attributed
$4,143,406
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $996.2K · FY2017–23$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,143,406 · 3
By mechanism
U01$3,334,185 · 1
P01$809,221 · 2
Top collaborators
- Louise C Showe5 shared
Most similar at Wistar Institute
Same institution · by research overlap
- Louise C Showe$10,986,130
- Luis J. Montaner$69,201,825
- David W. Speicher$30,175,378
- Qihong Huang$2,464,654
Others in their field
Other Emerging Leaders on “Site”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Beth Baseler · Leidos Biomedical Research, Inc.$118,180,593
- Kimberly Smith · Ppd Development Lp$115,671,664
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
Research focus
SiteGenetic SignatureResearch PersonnelDesignBaseProgramsFlexibilityExperimental AnalysisFundingData ManagementBiometryBiostatistics CoreExperimental DesignsExperimental StudyData CollectionElementsCommunicationAnticancer ResearchBiologyData AnalysesCost EffectiveData QualityCollaborationsBiological
Grant awards (10)
Biostatistics Core$168,617
P01 · FY2023 · CA · contact PI
Biostatistics Core$155,261
P01 · FY2022 · CA · contact PI
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer$448,182
U01 · FY2021 · CA
Biostatistics Core$159,061
P01 · FY2021 · CA · contact PI
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer$608,274
U01 · FY2020 · CA
Biostatistics Core$149,694
P01 · FY2020 · CA · contact PI
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer$819,590
U01 · FY2019 · CA
Biostatistics Core$176,588
P01 · FY2019 · CA · contact PI
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer$786,485
U01 · FY2018 · CA
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer$671,654
U01 · FY2017 · CA